Xanthophyll composition comprising lutein and zeaxanthin with enhanced bioavailability

The present invention relates to a xanthophyll composition comprising selective isomers of trans-R,R lutein and trans-R,R zeaxanthin in preferred particle size and pharmaceutically and/or nutraceutically acceptable excipients such as carriers, solubility enhancers, bioavailability enhancing agents,...

Full description

Saved in:
Bibliographic Details
Main Authors NALAWADE, Pravin, THAKARE, Ravindra, T.K., Sunil Kumar, LAL, Jangir Mohan, MORDE, Abhijeet
Format Patent
LanguageEnglish
Published 03.10.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a xanthophyll composition comprising selective isomers of trans-R,R lutein and trans-R,R zeaxanthin in preferred particle size and pharmaceutically and/or nutraceutically acceptable excipients such as carriers, solubility enhancers, bioavailability enhancing agents, antioxidants and optionally flavoring agents with selective ratio which exerts enhanced bioavailability. The xanthophyll composition at least 80% of total xanthophyll comprised of at least 65% by weight of trans-R,R lutein and at least 10 % by weight of trans-R,R zeaxanthin, which is prepared combinedly from marigold and paprika oleoresins with definite proportion to produce the preferred ratio of trans-R,R lutein and trans-R,R zeaxanthin.
Bibliography:Application Number: AU20200368221